Search

Search Constraints

You searched for: Author/Creator Aghemo, Alessio

Search Results

1. 12 weeks ombitasvir/paritaprevir–ritonavir + ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis. Issue 7 (July 2018)

2. A risk score based on baseline risk factors for predicting mortality in COVID-19 patients. (3rd June 2021)

4. Acute Allograft Rejection following Interferon Therapy for Hepatitis C in Recipients who have Returned to Dialysis after Kidney Transplant Failure: Case Study. Issue 11 (November 2014)

5. Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials. (18th October 2019)

6. Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy. (25th September 2019)

9. Assessing the impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian association for the study of the Liver. Issue 9 (September 2020)